Synapse - Center for Hematologic Malignancies

Results (13553)

A phase I dose-escalation study evaluating the effects of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with select relapsed or refractory hematologic malignancies

Meeting Abstract

Lesokhin, A. M.; Gutierrez, M.; Halwani, A. S.; Ansell, S. M.; Armand, P.; Borrello, I.; Segota, Z. E.; Cohen, A. D.; Talpaz, M.; Cattry, D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers

Meeting Abstract

Hong, D. S.; Younes, A.; Fayad, L.; Fowler, N. H.; Hagemeister, F. B.; Mistry, R.; Nemunaitis, J. J.; Borad, M. J.; Bryce, A. H.; Yamashita, M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ in patients with relapsed/refractory lymphoma

Meeting Abstract

Horwitz, S. M.; Flinn, I.; Patel, M. R.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Dunbar, J.; Kelly, P. F.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Evaluation of early response by anatomic imaging to predict survival among patients with group III rhabdomyosarcoma: A report from the Children's Oncology Group

Meeting Abstract

Hawkins, D. S.; Rosenberg, A. R.; Lyden, E.; Anderson, J. R.; Rodeberg, D. A.; Wolden, S. L.; Kao, S. C.; Parham, D.; Arndt, C. A. S.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Cytological and molecular remissions with blinatumomab treatment in second or later bone marrow relapse in pediatric acute lymphoblastic (ALL)

Meeting Abstract

Gore, L.; Zugmaier, G.; Handgretinger, R.; Locatelli, F.; Trippett, T. M.; Rheingold, S. R.; Bader, P.; Borkhardt, A.; Cooper, T. M.; O'Brien, M. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71

Meeting Abstract

Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Multivariate analysis of factors affecting overall survival, event free survival, and 60-day mortality among AML patients treated with CPX-351 or intensive chemotherapy

Meeting Abstract

Feldman, E. J.; Lancet, J. E.; Kolitz, J. E.; Hogge, D.; Tallman, M. S.; Goldberg, S. L.; Kovacsovics, T.; Louie, A. C.; Cortes, J. E.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL

Meeting Abstract

Dubrovsky, L.; Brea, E. J.; Veomett, N. J.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab

Meeting Abstract

Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save